Table 2.
Further clinical characteristics of keratitis cases
| Patient | Initial BCVA | Final BCVA | Ulcer location | Prior steroid | Penetrating keratoplasty | Treatment given | MIC N/V/A |
|---|---|---|---|---|---|---|---|
| 1 | 2.3 | 2.0 | C | No | Yes | N, K | 4/8/4 |
| 2 | 2.3 | 1.6 | – | – | – | – | 8/8/1 |
| 3 | 2.3 | 2.0 | C | No | – | N, K, F | 0.125/8/0.5 |
| 4 | 0.8 | 0.2 | C | Yes | – | A | 4/8/0.5 |
| 5 | 2.3 | 2.3 | C | No | Yes | N, A, F | 4/4/2 |
| 6 | 0.1 | 0.1 | C | Yes | – | N, K | 4/16/1 |
| 7 | 2.6 | 2.3 | – | No | Yes | N, K | 8/8/4 |
| 8 | 2.0 | 0.5 | C | No | – | N, K | 4/8/4 |
| 9 | 1.0 | 0.4 | – | – | – | A | – |
| 10 | 2.6 | 2.6 | C | No | Yes | K | 4/4/0.5 |
| 11 | 3.0 | 2.6 | C | – | Yes | A, K | 4/16/2 |
| 12 | 2.6 | 2.0 | C | No | Yes | N, K, A | 8/8/2 |
| 13 | 2.3 | 0.4 | C | No | – | A | 1/16/1 |
| 14 | 2.6 | 2.6 | C | No | Yes | A, K | 4/8/2 |
| 15 | 0.4 | 0.4 | C | No | – | N, K | 4/2/4 |
| 16 | 2.0 | 2.0 | C | No | Yes | N, A, K | 4/2/2 |
| 17 | 0.4 | 0.5 | C | No | – | N, K | 0.03/8/0.5 |
| 18 | 2.3 | 2.6 | C | No | Yes | A, K | 4/8/2 |
| 19 | 0.7 | 0.1 | C | No | – | N, K | 0.125/8/0.25 |
| 20 | 0.7 | 0.7 | P | No | – | N, K | 8/4/4 |
| 21 | 1.6 | 1.6 | – | – | – | – | 4/16/2 |
| 22 | 3.0 | 2.3 | C | No | Yes | A | 8/8/4 |
| 23 | 2.3 | – | – | No | – | – | 4/8/1 |
| 24 | 2.6 | 2.0 | C | No | Yes | K | 4/4/1 |
| 25 | 2.6 | 2.3 | C | No | Yes | A, K | 0.25/4/0.5 |
| 26 | 2.3 | 2.3 | C | No | Yes | A | 8/8/2 |
| 27 | 0.7 | 0.5 | C | Yes | – | A, K | 4/8/1 |
| 28 | 2.3 | 2.0 | C | No | Yes | A, K | 8/4/2 |
| 29 | 0.9 | 0.4 | P | Yes | – | A, K | – |
| 30 | 2.3 | – | C | No | Yes | A, F, K | – |
| 31 | 2.6 | 2.3 | C | Yes | Yes | A, K | 8/8/1 |
| 32 | 2.3 | 2.3 | P | – | Yes | N, K | 8/16/0.5 |
| 33 | 2.0 | 2.3 | C | No | – | A | 4/8/0.5 |
| 34 | 2.6 | 2.6 | – | – | Yes | A, K | 8/2/0.5 |
| 35 | 2.6 | 2.6 | C | – | Yes | A, K | 8/8/1 |
| 36 | 2.3 | 2.3 | – | Yes | Yes | A | 4/1/0.5 |
| 37 | 1.6 | – | – | No | – | A, K | 4/2/1 |
| 38 | 2.3 | 2.0 | P | No | – | – | 4/8/2 |
| 39 | 0.2 | 0 | C | No | – | N | 4/4/2 |
| 40 | 2.3 | 0.5 | C | No | Yes | A, K | 8/8/4 |
| 41 | 2.6 | 2.6 | C | Yes | Yes | A, K | 4/8/1 |
| Totals/means ± standard deviation | 1.9 ± 0.88 | 1.6 ± 0.96 | 29 C(br/)4 P |
Note: BCVAs are expressed in logarithm of the minimum angle of resolution (LogMAR).
Abbreviations: BCVA, best corrected visual acuity; C, in the central 6 mm of the cornea; P, peripheral; N, natamycin; A, amphotericin B; K, ketoconazole; F, fluconazole; MIC, minimum inhibitory concentration; n, natamycin; V, voriconazole.